Sales: $1.7 billion
Key Personnel: Christian Courtin-Clarins, chairman; Philip Shearer, chief executive officer; Dr. Olivier Courtin-Clarins, R&D director; Jonathan Zrihen, president, Clarins Groupe Americas.
Major Products: Clarins, ClarinsMen skin care and Azzaro and Thierry Mugler fragrances.
New Products: Double Serum, Body Lift Cellulite Control, ClarinsMen Ab Firming, BB Skin Perfecting Cream.
Comments: Privately-held Clarins derives about 66% of sales from skin care products and the remainder from fragrances. More than half of sales come from Europe, but with expansion in the US and growing operations in Asia (especially China and Korea), company executives expect the majority of sales to come from outside Europe in the next few years.
Ever since the company went private in 2008, Clarins has been mum about annual sales, but company executives remain staunch supporters of plant-based chemistry. In fact, its 80 researchers take upwards of 18 months to create a new product developed using an inventory of 1000 raw materials, according to Clarins. But even pure ingredients can’t eliminate office politics.
Last month, the company announced that the president of its fragrance group, Joël Palix, was leaving the company. He was replaced by Sandrine Groslier, who had been managing director of Clarins Fragrance Group France.
The announcement followed a recent restructuring within the Thierry Mugler fashion and fragrance divisions. That shakeup led to the departure of Mugler himself as artistic director of the fragrance brand.
Still, the shakeup hasn’t kept Clarins from cutting new deals. In June, the company inked an agreement with Italian fashion house Ittierre to develop new fragrances. That agreement follows Puig’s decision in March to have Clarins handle its North American distribution.